Trials / Completed
CompletedNCT03330288
Prospective Multicenter Non-interventional Study in Patients With Knee or Hip Osteoarthritis Having a Theraflex Treatment
Prospective Multicenter Non-interventional Study in Patients With Knee or Hip Osteoarthritis Having a Theraflex® Treatment to Evaluate Changes in Pain, Functions in Daily Living, and Quality of Life for an Observation Period up to 64 Weeks
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,102 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate how a long-term treatment with Theraflex during 64 weeks affects pain intensity in the affected knee or hip joint, the activity in daily living, the quality of life and patient satisfaction with treatment.
Detailed description
Other information that is planned for evaluation in this study includes consumption of Theraflex, intake of analgesics for joint pain relief and description of basic patient characteristics such as age, weight and body mass index and others.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Theraflex, BAY 874017 | The first three weeks which do have a different posology (3 capsules a day) according to the label should be entered as a distinct period to the treatment period with a recommended posology of 2 capsules a day |
Timeline
- Start date
- 2017-11-20
- Primary completion
- 2020-03-18
- Completion
- 2020-07-13
- First posted
- 2017-11-06
- Last updated
- 2021-10-14
- Results posted
- 2021-10-14
Locations
2 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT03330288. Inclusion in this directory is not an endorsement.